UK markets close in 3 hours 32 minutes
  • FTSE 100

    7,265.93
    +43.11 (+0.60%)
     
  • FTSE 250

    23,083.62
    +141.84 (+0.62%)
     
  • AIM

    1,229.86
    +0.85 (+0.07%)
     
  • GBP/EUR

    1.1885
    +0.0032 (+0.27%)
     
  • GBP/USD

    1.3812
    +0.0044 (+0.32%)
     
  • BTC-GBP

    45,473.10
    -238.49 (-0.52%)
     
  • CMC Crypto 200

    1,509.43
    +1,266.75 (+521.99%)
     
  • S&P 500

    4,566.48
    +21.58 (+0.47%)
     
  • DOW

    35,741.15
    +64.13 (+0.18%)
     
  • CRUDE OIL

    83.94
    +0.18 (+0.21%)
     
  • GOLD FUTURES

    1,804.20
    -2.60 (-0.14%)
     
  • NIKKEI 225

    29,106.01
    +505.60 (+1.77%)
     
  • HANG SENG

    26,038.27
    -93.76 (-0.36%)
     
  • DAX

    15,751.86
    +152.63 (+0.98%)
     
  • CAC 40

    6,759.18
    +46.31 (+0.69%)
     

IBA – ACQUISITION OF OWN SHARES

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Immediate Release – October 1st, 2021

Louvain-la-Neuve, Belgium, October 1st, 2021 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on June 29th, 2021.

Under this program, IBA has requested a financial intermediary to repurchase up to 250.000 IBA ordinary shares on its behalf under the terms of a discretionary mandate agreement with validity until December 30th, 2021, effective as from June 30th, 2021, to cover the company’s obligations under a long term incentive plan for certain members of its personnel.

In the framework of this share buyback program, IBA repurchased 23.323 IBA shares on Euronext Brussels in the period from September 24th, 2021 up to and including September 30th, 2021, as follows:

The total number of shares purchased under this program therefore amounts to 231.755. As a result, the current situation with respect to treasury shares (held directly by IBA SA and indirectly through its subsidiary IBA Investments SCRL) is the follow
ing:

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,500 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

Contact person

IBA
Christian Matton,
IBA Chief Legal Officer
shareholderrelations@iba-group.com

Attachment


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting